Future Of US FDA’s Diversity Action Plan Guidance ‘Up In The Air’ As Statutory Deadline Looms

 
• By Sue Sutter

A 26 June deadline looms for the final guidance even though a draft guidance was removed from the agency’s website to comply with President Trump’s gender ideology executive order. The concepts underpinning the guidance are still relevant, legal experts say.

Questions in a jar
The timing and content of an FDA diversity action plan final guidance are uncertain. (Shutterstock)

More from Diversity & Inclusion

More from Conferences